Transatlantique Private Wealth LLC Sells 2,102 Shares of Colgate-Palmolive Company $CL

Transatlantique Private Wealth LLC cut its stake in Colgate-Palmolive Company (NYSE:CL) by 25.7% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 6,069 shares of the company’s stock after selling 2,102 shares during the period. Transatlantique Private Wealth LLC’s holdings in Colgate-Palmolive were worth $552,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors also recently modified their holdings of the stock. Brighton Jones LLC grew its position in shares of Colgate-Palmolive by 4.4% during the 4th quarter. Brighton Jones LLC now owns 10,578 shares of the company’s stock worth $962,000 after buying an additional 450 shares during the period. Wayfinding Financial LLC acquired a new stake in shares of Colgate-Palmolive during the 1st quarter worth approximately $69,000. World Investment Advisors grew its position in shares of Colgate-Palmolive by 24.1% during the 1st quarter. World Investment Advisors now owns 11,769 shares of the company’s stock worth $1,103,000 after buying an additional 2,282 shares during the period. Concurrent Investment Advisors LLC grew its position in shares of Colgate-Palmolive by 98.7% during the 1st quarter. Concurrent Investment Advisors LLC now owns 22,408 shares of the company’s stock worth $2,100,000 after buying an additional 11,131 shares during the period. Finally, Penserra Capital Management LLC grew its position in shares of Colgate-Palmolive by 398.6% during the 1st quarter. Penserra Capital Management LLC now owns 10,651 shares of the company’s stock worth $997,000 after buying an additional 8,515 shares during the period. 80.41% of the stock is owned by institutional investors.

Colgate-Palmolive Stock Down 2.7%

Colgate-Palmolive stock opened at $74.94 on Tuesday. The stock has a market capitalization of $60.56 billion, a PE ratio of 21.05, a price-to-earnings-growth ratio of 4.44 and a beta of 0.34. Colgate-Palmolive Company has a twelve month low of $74.54 and a twelve month high of $100.18. The company has a quick ratio of 0.57, a current ratio of 0.89 and a debt-to-equity ratio of 6.79. The company has a 50 day moving average of $80.26 and a 200-day moving average of $86.14.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings data on Friday, October 31st. The company reported $0.91 EPS for the quarter, topping analysts’ consensus estimates of $0.89 by $0.02. The business had revenue of $5.13 billion for the quarter, compared to analyst estimates of $5.17 billion. Colgate-Palmolive had a net margin of 14.55% and a return on equity of 377.63%. The firm’s revenue for the quarter was up 1.9% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.91 earnings per share. On average, equities research analysts anticipate that Colgate-Palmolive Company will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 14th. Stockholders of record on Friday, October 17th will be given a $0.52 dividend. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.8%. The ex-dividend date of this dividend is Friday, October 17th. Colgate-Palmolive’s payout ratio is currently 58.26%.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently commented on the stock. Deutsche Bank Aktiengesellschaft set a $86.00 price target on shares of Colgate-Palmolive in a research report on Friday, October 10th. Piper Sandler assumed coverage on shares of Colgate-Palmolive in a report on Friday, October 3rd. They set a “neutral” rating and a $84.00 price objective for the company. Bank of America decreased their price objective on shares of Colgate-Palmolive from $98.00 to $88.00 and set a “buy” rating for the company in a report on Wednesday, October 8th. Citigroup reduced their price target on shares of Colgate-Palmolive from $105.00 to $95.00 and set a “buy” rating for the company in a report on Monday. Finally, Evercore ISI reduced their price target on shares of Colgate-Palmolive from $100.00 to $94.00 and set an “outperform” rating for the company in a report on Monday. Nine investment analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $90.00.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.